Literature DB >> 17354133

Magnetic resonance imaging with liver-specific contrast agent in primary amyloidosis and intrahepatic cholestasis.

J M Møller1, E Santoni-Rugiu, E Chabanova, V Løgager, A B Hansen, H S Thomsen.   

Abstract

Magnetic resonance imaging (MRI) findings in hepatic amyloidosis are not well defined. Here, we report on a patient with renal failure caused by primary amyloidosis (AL type) who developed jaundice. Ultrasound and computed tomography were normal except for some ascites. MRI with oral manganese-containing contrast agent revealed several focal areas without contrast uptake in the hepatocytes and no bile secretion after 8 hours. No extrahepatic bile obstructions were found. Liver biopsy showed severe intraportal, vascular, and parenchymal amyloidosis causing severe cholestasis and atrophy of hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17354133     DOI: 10.1080/02841850601128959

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  2 in total

Review 1.  Other types of diffuse liver disease: is there a way to do it?

Authors:  Hilton Leao Filho; Camila Vilela de Oliveira; Natally Horvat
Journal:  Abdom Radiol (NY)       Date:  2020-11

2.  Hepatic Amyloidosis: Something That Can camouflage and Deceive our Perception!

Authors:  Anirudh V Nair; Manish Kumar Yadav; Madhavan N Unni; C M Simi; K A Biji; K S Manoj; Shabeer Ali; Ajith K Nair
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Apr-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.